MX2022002475A - Concentrado y aislado de cannabinoide, metodo para su obtencion y uso. - Google Patents

Concentrado y aislado de cannabinoide, metodo para su obtencion y uso.

Info

Publication number
MX2022002475A
MX2022002475A MX2022002475A MX2022002475A MX2022002475A MX 2022002475 A MX2022002475 A MX 2022002475A MX 2022002475 A MX2022002475 A MX 2022002475A MX 2022002475 A MX2022002475 A MX 2022002475A MX 2022002475 A MX2022002475 A MX 2022002475A
Authority
MX
Mexico
Prior art keywords
isolate
obtaining
same
cannabinoid concentrate
cannabinoid
Prior art date
Application number
MX2022002475A
Other languages
English (en)
Inventor
Del Greco Giovanni Venturini
Del Greco Lorenzo Venturini
Deborha Decorti
Original Assignee
Herbolea Biotech S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Herbolea Biotech S P A filed Critical Herbolea Biotech S P A
Publication of MX2022002475A publication Critical patent/MX2022002475A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D3/00—Distillation or related exchange processes in which liquids are contacted with gaseous media, e.g. stripping
    • B01D3/10—Vacuum distillation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Fats And Perfumes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se relaciona con un concentrado y aislado de cannabinoide con un alto contenido de formas ácidas de los cannabinoides, método de obtención del mismo y su uso que comprende proporcionar un extracto de lípido usando entre otras cosas parafina y someterla a destilación específica.
MX2022002475A 2019-08-27 2019-08-27 Concentrado y aislado de cannabinoide, metodo para su obtencion y uso. MX2022002475A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2019/072843 WO2021037343A1 (en) 2019-08-27 2019-08-27 Cannabinoid concentrate and isolate, method of obtaining the same and use thereof

Publications (1)

Publication Number Publication Date
MX2022002475A true MX2022002475A (es) 2022-03-22

Family

ID=67999599

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022002475A MX2022002475A (es) 2019-08-27 2019-08-27 Concentrado y aislado de cannabinoide, metodo para su obtencion y uso.

Country Status (15)

Country Link
US (1) US20220401405A1 (es)
EP (1) EP4022077A1 (es)
CN (1) CN114761572A (es)
AR (1) AR116672A1 (es)
AU (1) AU2019463310A1 (es)
BR (1) BR112022003557A2 (es)
CA (1) CA3149047A1 (es)
CO (1) CO2022003480A2 (es)
EC (1) ECSP22018842A (es)
IL (1) IL290751A (es)
MX (1) MX2022002475A (es)
PE (1) PE20221403A1 (es)
UY (1) UY38385A (es)
WO (1) WO2021037343A1 (es)
ZA (1) ZA202203193B (es)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403126B1 (en) 1999-05-26 2002-06-11 Websar Innovations Inc. Cannabinoid extraction method
GB2393182B (en) 2002-09-23 2007-03-14 Gw Pharma Ltd Method of preparing cannabidiol from plant material
GB2495118B (en) * 2011-09-29 2016-05-18 Otsuka Pharma Co Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
ES2576464B2 (es) 2013-11-11 2017-01-26 The Werc Shop, LLC Procesado sin disolvente, sistema y métodos
US9186386B2 (en) 2014-04-17 2015-11-17 Gary J. Speier Pharmaceutical composition and method of manufacturing
US9340475B2 (en) 2014-07-02 2016-05-17 Cv Sciences, Inc. Process for generating hemp oil with a high cannabidiol (CBD) content
EP3209312A1 (en) * 2014-10-21 2017-08-30 United Cannabis Corp. Cannabis extracts and methods of preparing and using same
EP3247371B1 (en) * 2015-01-22 2020-04-01 Phytoplant Research S.L. Methods of purifying cannabinoids, compositions and kits thereof
EP3274321B8 (en) 2015-03-23 2019-10-23 Echo Pharmaceuticals B.V. Cannabidiol isolate from industrial-hemp and use thereof in pharmaceutical and/or cosmetic preparations
GB2541191A (en) 2015-08-10 2017-02-15 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
EP3150264A1 (de) * 2015-09-30 2017-04-05 Bionorica Ethics GmbH Vakuumdestillation zur anreicherung von cbd
IL248150B (en) * 2016-09-29 2018-05-31 Garti Nissim A method for selective extraction of cannabinoid from plant origin
AU2018207955B2 (en) 2017-01-14 2022-10-06 Herbolea Biotech S.R.L. Enzyme-assisted lipid-based extraction and stabilization of phyto-cannabinoids and terpens and products obtained thereof
US10888595B2 (en) * 2017-04-18 2021-01-12 Jose Rivas Apparatus for preparation of pharmacologically-relevant compounds from botanical sources
US10828341B2 (en) * 2017-04-18 2020-11-10 Jose Rivas Method for preparation of pharmacologically-relevant compounds from botanical sources
US11759724B2 (en) * 2017-04-18 2023-09-19 Jose Rivas Method and apparatus for preparation of pharmacologically-relevant compounds from botanical sources
CN107095302A (zh) * 2017-05-09 2017-08-29 何宗迅 大麻素类混合物及其在食品工业中的应用
US10189762B1 (en) * 2017-07-07 2019-01-29 Orochem Technologies, Inc. Process for purification and separation of cannabinoids, from dried hemp and cannabis leaves
GB2564459B (en) 2017-07-12 2022-03-09 Gw Res Ltd Use of cannabinoids in the treatment of a neurodegenerative disease or disorder
EP3461545A1 (de) * 2017-09-30 2019-04-03 Bionorica Ethics GmbH Kurzwegdestillation im vakuum zur anreicherung von naturstoffen

Also Published As

Publication number Publication date
ECSP22018842A (es) 2022-05-31
EP4022077A1 (en) 2022-07-06
BR112022003557A2 (pt) 2022-05-24
CO2022003480A2 (es) 2022-05-31
IL290751A (en) 2022-07-01
UY38385A (es) 2021-01-29
PE20221403A1 (es) 2022-09-15
WO2021037343A1 (en) 2021-03-04
CA3149047A1 (en) 2021-03-04
AU2019463310A1 (en) 2022-04-07
AR116672A1 (es) 2021-06-02
CN114761572A (zh) 2022-07-15
US20220401405A1 (en) 2022-12-22
ZA202203193B (en) 2023-09-27

Similar Documents

Publication Publication Date Title
EA201890883A1 (ru) Вакуумная дистилляция для обогащения каннабидиола
MX2018016411A (es) Resinas de cannabis descarboxiladas, usos de las mismas y metodos para elaborarlas.
PH12018500816A1 (en) Alcoholic beverage and method of making the same
AU2016261707A8 (en) Use of cannabis to treat fibromyalgia, methods and compositions thereof
MY160867A (en) Methods for extracting and isolating constituents of cellulosic material
MX2019013538A (es) Proceso de extraccion de thca sin solventes.
MX2020001443A (es) Sistema y métodos de extracción fitoquímica para extraer fitoquímicos de plantas incluidas las plantas de la familia cannabaceae sensu stricto.
UY36696A (es) Un método y un aparato para formar una fracción de lignina, una composición de lignina y su uso
BR112017002005A2 (pt) tubo híbrido, e, estrutura s de assento de avião.
MY184650A (en) Antioxidant composition for oil, preparation method therefor, cooking oil containing same, and method for preparing cooking oil
AU2015217822A8 (en) Method for producing vitamin E-enriched, especially tocotrienol-enriched, compositions from natural oils
CO2019003427A2 (es) Métodos para mejorar el resabio de bebidas alcohólicas usando alulosa
MX2019007884A (es) Metodo de tratamiento de insectos que comprende la separacion de cuticulas de la parte blanda de los insectos y despues la separacion de la parte blanda en tres fracciones.
MX2020005653A (es) Compuestos para la separacion de elementos de tierras raras y metales s, p, d, metodo de separacion y uso de estos.
Karrer et al. JEMS. 2014 Apr; 39 (4): 26-32. Simple thoracostomy. Moving beyond needle decompression in traumatic cardiac arrest.
BR112017014297A2 (pt) método para preparar um concentrado de café, e, concentrado de café.
SA520411552B1 (ar) طرق ووسائل لاستخلاص الزيت من فاكهة زيتية
ZA202203193B (en) Cannabinoid concentrate and isolate, method of obtaining the same and use thereof
BR112017014298A2 (pt) método para preparar um concentrado de café, e, concentrado de café.
BR112015020365A2 (pt) fração bioativa derivada de fruta, composição, e método para isolar uma fração bioativa
MX2021004467A (es) Productos lacteos filtrados acidos reducidos en carbohidratos.
EP4342514A3 (en) Device for compressing a compressible part of a catheter pump
BR112022012525A2 (pt) Isolado de proteína de ervilha com baixo teor de lipídios
MY184673A (en) A process of preparing vitamin e concentrate
WO2019022542A3 (ko) 양이온을 이용한 세포밖 소포체의 분리 방법